QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.104.071027v1 311/2/677    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Minkeviciene, R. Articles by Tanila, H. Search for Related Content PubMed PubMed Citation Articles by Minkeviciene, R. Articles by Tanila, H. Pubmed/NCBI databases Compound via MeSH Substance via MeSH

BEHAVIORAL PHARMACOLOGY

Memantine Improves Spatial Learning in a Transgenic Mouse Model of Alzheimer's Disease

Department of Neuroscience and Neurology, University of Kuopio, Finland (R.M., H.T.); Forest Research Institute, Jersey City, New Jersey (P.B.); and Department of Neurology, Kuopio University Hospital, Kuopio, Finland (H.T.)

Memantine, a low- to moderate-affinity uncompetitive N-methyl-D-aspartate receptor antagonist, has been shown to improve learning and memory in several pharmacological models of Alzheimer's disease (AD). In the present study, the effect of memantine on locomotor activity, social behavior, and spatial learning was assessed in a transgenic mouse model of AD. Eight-month-old male C57BL/6J mice carrying mutated human APP and PS1 genes (APP/PS1) and their nontransgenic (NT) litter mates were administered a therapeutic dose of memantine (30 mg/kg/day p.o.) for 2 to 3 weeks. At this age, APP/PS1 mice show elevated levels of -amyloid peptides in several brain regions. APP/PS1 mice exhibited less exploratory rearing and increased aggressive behavior compared with NT mice. In the water maze test for spatial learning, APP/PS1 mice had longer escape latencies to both hidden and visible platforms, but they did not differ from NT mice in their swimming speed. Memantine significantly improved the acquisition of the water maze in APP/PS1 mice without affecting swimming speed. Memantine did not affect either locomotor activity or aggressive behavior in either genotype. These data indicate that memantine improves hippocampus-based spatial learning in a transgenic mouse model of AD without producing nonspecific effects on locomotion/exploratory activity.

Address correspondence to: Dr. Heikki Tanila, Department of Neuroscience and Neurology, University of Kuopio, P.O. Box 1627, 70211 Kuopio, Finland. E-mail: heikki.tanila{at}uku.fi

This article has been cited by other articles:

				H. van Praag, M. J. Lucero, G. W. Yeo, K. Stecker, N. Heivand, C. Zhao, E. Yip, M. Afanador, H. Schroeter, J. Hammerstone, et al. Plant-Derived Flavanol (-)Epicatechin Enhances Angiogenesis and Retention of Spatial Memory in Mice J. Neurosci., May 30, 2007; 27(22): 5869 - 5878. [Abstract] [Full Text] [PDF]

				H. Geerts and G. T. Grossberg Pharmacology of Acetylcholinesterase Inhibitors and N-methyl-D-aspartate Receptors for Combination Therapy in the Treatment of Alzheimer's Disease J. Clin. Pharmacol., July 1, 2006; 46(suppl_1): 8S - 16S. [Abstract] [Full Text] [PDF]

				J. L. Molinuevo, A. Llado, and L. Rami Memantine: Targeting glutamate excitotoxicity in Alzheimer's disease and other dementias American Journal of Alzheimer's Disease and Other Dementias, March 1, 2005; 20(2): 77 - 85. [Abstract] [PDF]